LOG IN   JOIN   BLOG SEARCH   ALL DIARIES

Website Blog
Blog
Issues
Take Action
Videos
Donate
About
Youth Resources
My Sistahs
Advocates For Youth
 
Blog - Amplify your voice

Saturday, September 26, 2009 at 8:34:00 PM EDT

According to this article by WebMD an FDA panel has recommended approval for the use of Gardisil, an HPV vaccine, in males.

What does this mean for men and women? Although the link between cervical cancer and HPV is well known, it is less known that HPV also contributes to penile cancer in men, and anal and oral cancer in both sexes.

Hopefully, wider use of this vaccine, in addition to improved education about this virus causes a decrease in HPV diagnoses in years to come.

For more information on HPV, check out this link from the Center for Disease Control.

Share this entry:  del.icio.us | Facebook |  MySpace | Digg It! | Tweet This
Comments
I feel so mixed about the HPV vaccine - but I also think it's ridiculous that it was only approved for women in the beginning.  What I found particularly of interest in the article that you shared (and thanks for sharing it!) was this:
Gardasil is up for FDA consideration only as a way to prevent genital warts in boys -- not to prevent cancer in males or to curb transmission of the HPV virus to women.

I find it so worrisome that all of the media about the HPV vaccine has been focused on cancer prevention in women and there has been very little talk about safer sex.  The ways that contraceptives have been studied and offered has put all of the responsibility on women and the HPV vaccine is no different.  I've had friends who wanted to be tested for HPV but were refused because they were men (and presumably HPV wouldn't directly affect them).  But the effects on their female partners are potentially deadly!  And still the CDC and FDA isn't looking at that - instead they're looking at genital warts prevention.  I think public health should be about curbing infection rates not just preventing conditions.



# Posted By  love-and-organizing | 9/27/09 10:30 AM | Report | Reply